Latest news

We are extremely proud of what we have achieved during the pandemic to support so many more people needing our help, despite losing a third of our income.

We are working hard to ensure that people with high cholesterol are detected as early as possible and receive the support they need to prevent premature death and improve health and wellbeing.

We’re with you every step of the journey!

Join us for a unique, expert-led series of interactive broadcasts providing practical advice and guidance for the whole primary care team confronted with the challenges of caring for patients suffering from Long Covid.

Registration is completely FREE and CPD points are awarded for attendance. Also recorded for on-demand viewing. 

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Join an afternoon session on an introduction to the basics of cholesterol at the HEART UK conference on 20 July

Understanding cholesterol results 
Spotlight on diet and its impact on cholesterol
The impact of diet on cholesterol 
Diet and cholesterol: from science to practice
Diabetes and cholesterol: exploring dietary factors.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

Dr Derek Connolly, Consultant Interventional Cardiologist and the Director of Research and Development at Birmingham City Hospital will chair a session exploring solutions to the gaps in lipid treatment with speaker Dr Susan Connolly, Consultant Cardiologist at Enniskillen.

Clinical Certainties and Uncertainties: what remains unresolved?

We are delighted that Professor Andrew Neil, Emeritus Professor of Clinical Epidemiology University of Oxford, Wolfson College will speak at the HEART UK conference on 7 July.

This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies

We are delighted to welcome Prof Sotirios (Sam) TSIMIKAS to the HEART UK conference on 7 July to present current and future therapeutic agents and interventions targeting Lp(a) and oxPLs.

Over and underestimation of Lp(a) due to its different molecular weight isoforms has led to bias in many studies leading to underestimation of its strength as a cardiovascular risk factor.

Prof Steve HUMPHRIES will be presenting at the HEART UK conference on Wednesday 7th July.

How knowing that a patient with clinical FH has a polygenic and not a monogenic cause for their phenotype is key in the clinician deciding on the appropriate patient care pathway.